• Bedaquiline: Transforming Tuberculosis and Cancer Stem Ce...

  2025-10-21

  Bedaquiline stands at the forefront as a diarylquinoline antibiotic, offering unmatched potency against multi-drug resistant tuberculosis and cancer stem cells. This guide delivers actionable workflows, comparative advantages, and troubleshooting strategies to maximize research impact in infectious disease and oncology.

• Bedaquiline: Scientific Frontiers in Host-Pathway Modulation

  2025-10-20

  Explore how Bedaquiline, a diarylquinoline antibiotic and Mycobacterium tuberculosis F1FO-ATP synthase inhibitor, is redefining multi-drug resistant tuberculosis treatment and cancer research through advanced host-pathway modulation. This in-depth analysis unveils novel therapeutic strategies and mechanistic insights distinct from existing research guides.

• Bedaquiline: Revolutionizing Drug-Resistant Tuberculosis ...

  2025-10-19

  Bedaquiline stands apart as a diarylquinoline antibiotic, uniquely targeting Mycobacterium tuberculosis F1FO-ATP synthase and inhibiting cancer stem cell metabolism. This guide delivers optimized workflows, advanced troubleshooting, and translational insights for researchers combating multi-drug resistant tuberculosis and cancer stem cell expansion.

• Cisapride (R 51619): Deep Phenotyping Tools for Cardiac a...

  2025-10-18

  Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist, powers next-generation research in 5-HT4 signaling and hERG channel inhibition. This article uniquely examines its integration with iPSC-derived models and deep learning for advanced cardiac and gastrointestinal studies.

94 records 7/7 page Previous First page 上5页 67